Quercis Pharma AG is leveraging its novel antithrombotic platform to deliver safe and innovative treatments to patients with a variety of complex diseases that are poorly addressed by today’s medicines and is committed to providing affordable access to these potentially life-saving therapies.
Location: Switzerland, Zug
Employees: 11-50
Total raised: $150M
Founded date: 2019
Investors 1
| Date | Name | Website |
| - | Oak Invest... | oakvc.com |
Funding Rounds 1
| Date | Series | Amount | Investors |
| 21.12.2021 | Private Eq... | $150M | - |
Mentions in press and media 7
| Date | Title | Description |
| 26.07.2024 | Leading innovation: 10 promising European startups focusing on biopharmaceuticals | Biopharmaceuticals, often known as bio-pharma, represent a dynamic sector within the pharmaceutical industry that uses biological processes to develop drugs and therapies. Unlike traditional pharmaceuticals, which are typically synthesized ... |
| 21.12.2021 | Quercis Pharma Secures USD 150 Million Investment Commitment | |
| 09.12.2021 | Quercis Pharma Secures USD 150 Million Investment Commitment from GEM as Company Seeks to Go Public | ZUG, Switzerland, Dec. 9, 2021 /PRNewswire/ -- Quercis Pharma AG, a private, clinical stage biopharmaceutical company leveraging its novel antithrombotic platform, today announced that it has signed an Agreement with GEM Global Yield LLC SC... |
| 19.05.2021 | Western New England University and Quercis Pharma Sign Exclusive Worldwide License Agreements | SPRINGFIELD, Mass. and ZUG, Switzerland, May 19, 2021 /PRNewswire/ -- Quercis Pharma AG, a private, clinical stage biopharmaceutical company, has signed a worldwide license agreement with Western New England University (WNE) of Springfield,... |
| 22.04.2021 | Senior leadership appointments at fintech and pharma startups | |
| 22.04.2021 | Senior leadership appointments at fintech and pharma startups | Jörg Bode, a financial expert with recognised leadership skills and a long career at renowned investment banks, is the new CEO of the Zurich-based provider of creates off-balance sheet securitisation platforms GenTwo. He initially made his ... |
| 13.04.2021 | Quercis Announces Executive Leadership Appointments | ZUG, Switzerland, April 13, 2021 /PRNewswire/ -- Quercis Pharma AG, a private, clinical stage biopharmaceutical company leveraging its novel antithrombotic platform, today announces the appointment of several new executives to the Company's... |